Research Background
Long-read sequencing technology is revolutionizing genetic diagnostics by enabling the detection of complex structural variants (SVs) and deep intronic variants (DIVs) missed by traditional WES or Sanger sequencing. However, when these advanced techniques uncover rare variants in non-coding regions, such as transposon insertions, rapidly assessing their pathogenicity becomes the new challenge. A recent study on Tuberous Sclerosis Complex (TSC) successfully utilized the RDDC RNA Splicing Prediction Model (RNA Splicer) AI tool to provide critical theoretical support for the pathogenic mechanism of a rare TSC2 gene Alu insertion discovered by long-read sequencing.
Research Challenge: Assessing the Pathogenicity of a Rare Intronic Alu Insertion
The study performed targeted long-read sequencing on 26 TSC patients who were negative for mutations by conventional testing (NMI). In one patient (TSC-T20), the team identified a de novo retrotransposon insertion of an Alu element into an intron of the TSC2 gene—a first for TSC patients. This represented an extremely rare and complex variant type. The core challenge for the team was to determine if, and how, this Alu element, buried deep within an intron, interfered with the normal splicing of the TSC2 gene to cause the disease.
RDDC's Precise Prediction: Unveiling a Pseudoexon Insertion Mechanism
To evaluate the pathogenic mechanism of this Alu insertion in the absence of patient RNA samples for experimental validation, the research team employed the RDDC RNA Splicing Prediction Model bioinformatics AI tool. RDDC's analysis provided a clear and specific in silico prediction: the newly inserted Alu element would likely cause the aberrant insertion of an 82 bp pseudoexon into the mature mRNA.
This prediction was highly significant. It clearly indicated that the Alu insertion was not a "silent" intronic variant but would instead activate cryptic splice sites, generating an aberrant transcript containing an 82 bp pseudoexon. This, in turn, would disrupt normal splicing and lead to a dysfunctional TSC2 protein.
Case Value: RDDC Provides Theoretical Support for Novel, Complex Variants
This case powerfully demonstrates that RDDC RNA Splicer is a robust analytical tool for researchers confronting complex non-coding variants discovered by new technologies like long-read sequencing. It provides rapid, reliable predictions of pathogenic mechanisms (such as pseudoexon insertion) for rare intronic events (like Alu transposon insertions), offering critical theoretical support for variant pathogenicity assessment. This "new-tech discovery + RDDC prediction" paradigm not only expands the pathogenic mutation spectrum of TSC but also highlights the importance of AI prediction tools in deciphering complex genetic variations, guiding the direction for future functional studies.
Content Source and Disclaimer
This article is a compilation and interpretation of the scientific study cited below, intended to highlight the application of RDDC bioinformatics tools. All research data and conclusions belong to the original authors and publication.
Original Article:
Duan J, Pan S, Ye Y, et al. Uncovering hidden genetic variations: long-read sequencing reveals new insights into tuberous sclerosis complex. Frontiers in Cell and Developmental Biology. 2024 Feb 16;12:1353208.
Article Link: https://pubmed.ncbi.nlm.nih.gov/39144255/
